ACUVAX LIMITED(ACU)

The securities of Activistic Limited (the "Company") will be reinstated to official quotation as from 10 am EDST on 15 May 2015, following the Company's compliance with listing rule 11.1.3 and chapters 1 and 2 of the ASX Listing Rules. 86,338,988 ordinary shares fully paid Security Code ACU

name changed to Activistic Limited

issues a supplementary prospectus

releases an amended prospectus timetable

lodges a prospectus for an offer of 40,000,000 Shares at an issue price of $0.10 each to raise $4,000,000 before costs with provision for oversubscriptions of up to an additional 20,000,000 Shares at the same issue price to raise up to a maximum of $6,000,000 before costs

the 1 for 10 securities consolidation has now been finalised.

we understand that on or about this date the company consolidated its shares 1 for 10

The securities of Acuvax Limited (the "Company") will be suspended from official quotation prior to the commencement of trading on Thursday 12 March 2015, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature and scale of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. Security Code: ACU

The suspension of trading in the securities of Acuvax Limited (the "Company") will be lifted from the commencement of trading tomorrow, Tuesday, 26 August 2014, following receipt of an announcement regarding completion of a capital raising. Security Code: ACU

resolutions considered at the general meeting were passed unanimously on a show of hands

a General Meeting of the Company will be held at Suite 4, 16 Ord Street West Perth, Western Australia on 30 July 2014 at 10:00AM (WST)

releases to the market a copy of the Company's corporate presentation that will be delivered to investors and their brokers during the upcoming investor presentations

company has executed a binding heads of agreement to acquire 100 % of all rights and title in all the issued capital Activistic Pty Ltd

confirms terms for a placement to sophisticated and professional investors to raise up to $600,000. Up to 1,200,000,000 shares will be placed to investors at an issue price of $0.0005 per share to raise a total of $600,000

The ASX has made enquiries of the Company in that it has asked of the Company: ï‚· to provide a market update as to its status; ï‚· the plans the Company may have for trading in its securities to resume; and ï‚· the Company's progress in implementing those plans In response the Company has advised the market that Acuvax has appointed Mr Alex Bajada to its board of Directors

the results of the Annual General Meeting in accordance with listing rule 3.13.2 and section 251AA of the Corporations Act. - resolutions where passed unanimously on a show of hands

the Annual General Meeting of Shareholders of Acuvax Limited will be held at the Suite 4, 16 Ord Street, West Perth on Wednesday 27 th November 2013 commencing at 2:00 PM WST

releases Annual Report to shareholders

The Boards of Acuvax Ltd and Biolife Science Ltd are pleased to announce that the exposure period for the Acuvax Offer to raise up to $5m to fund Phase 2 trials of its HERVaxx cancer immunotherapy has now ended and that the Offer is now open. The Prospectus and Application Form are available on the Acuvax website at: www.acuvax.com.au

we understand that on or about this date the company consolidated its shares 1 for 200

The securities of Acuvax Limited (the "Company") will be suspended from official quotation from the commencement of trading tomorrow, Friday 22 March 2013, pending the outcome of a resolution at the Company" general meeting to approve a change in the scale of the Company" activities. The Company" securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. Security Code: ACU

name changed from Avantogen Limited